Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DT3OE6
|
|||
| Drug Name |
AL102
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Desmoid tumour [ICD-11: 2F7C] | Phase 2 | [1] | |
| Company |
Ayala Pharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04871282) A Study of AL102 in Patients With Progressing Desmoid Tumors (RINGSIDE). U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Ayala Pharmaceuticals. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.